Faeth Therapeutics (FTH) Interest Coverage Ratio Growth (1y) (2021 - 2026)
Faeth Therapeutics (FTH) Interest Coverage Ratio Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -60.78% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | -25.59% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1,170.12% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 751.68% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 99.48% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -53.46% |
| 10 | Faeth Therapeutics | 179.31 Mn | 179.31 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -26.69% |
| Mar 31, 2026 | 8.13% |
| Dec 31, 2025 | 100.79% |
| Sep 30, 2025 | -20.62% |
| Jun 30, 2025 | -19.04% |
| Mar 31, 2025 | 19.13% |
| Dec 31, 2024 | -9,846.92% |
| Sep 30, 2024 | 45.53% |
| Jun 30, 2024 | 58.82% |
| Mar 31, 2024 | 29.62% |
| Dec 31, 2023 | -107.73% |
| Sep 30, 2023 | -90.10% |
| Jun 30, 2023 | 92.66% |
| Mar 31, 2023 | 47.75% |
| Dec 31, 2022 | 305.91% |
| Sep 30, 2022 | -193.34% |
| Jun 30, 2022 | -8,587.50% |
| Mar 31, 2022 | -15,090.36% |
| Dec 31, 2021 | -699.84% |
| Sep 30, 2021 | 91.62% |